JAM
ATRS

JW Asset Management’s Antares Pharma, Inc. ATRS Stock Holding History

JW Asset Management’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-380,524
Closed -$1.25M – 14
2019
Q2 		$1.25M Sell
380,524
-1,540,000
-80% -$4.46M 0.67% 10
2019
Q1 		$5.82M Hold
1,920,524
– – 2.99% 8
2018
Q4 		$5.22M Hold
1,920,524
– – 3.85% 7
2018
Q3 		$6.45M Buy
1,920,524
+100,000
+5% +$309K 3.48% 5
2018
Q2 		$4.7M Buy
1,820,524
+50,000
+3% +$124K 2.99% 6
2018
Q1 		$3.9M Sell
1,770,524
-107,799
-6% -$243K 3.84% 6
2017
Q4 		$3.74M Buy
1,878,323
+206,367
+12% +$449K 3.98% 5
2017
Q3 		$5.42M Hold
1,671,956
– – 3.97% 6
2017
Q2 		$5.38M Buy
1,671,956
+362,431
+28% +$1.03M 3.43% 6
2017
Q1 		$3.72M Buy
1,309,525
+216,695
+20% +$521K 0.77% 14
2016
Q4 		$2.55M Buy
1,092,830
+252,205
+30% +$480K 1.69% 15
2016
Q3 		$1.41M Buy
840,625
+364,728
+77% +$447K 0.97% 21
2016
Q2 		$500K Buy
475,897
+333,699
+235% +$322K 0.4% 27
2016
Q1 		$124K Hold
142,198
– – 0.08% 33
2015
Q4 		$172K Hold
142,198
– – 0.06% 36
2015
Q3 		$242K Hold
142,198
– – 0.09% 44
2015
Q2 		$296K Buy
142,198
+100,150
+238% +$243K 0.09% 43
2015
Q1 		$114K Buy
42,048
+112
+0.3% +$284 0.05% 43
2014
Q4 		$108K Buy
+41,936
New +$94.2K 0.08% 44

Other funds holding ATRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
MWP
MYCIO Wealth Partners Philadelphia, Pennsylvania $502M AUM 11.65% 1-Year Est. Return

JW Asset Management's ATRS Position: Q3 2019 in Review

JW Asset Management sold out of Antares Pharma, Inc. (ATRS) in Q3 2019, closing a stake of 380,524 shares — an estimated $1.25M sold.

JW Asset Management first reported a position in ATRS in Q4 2014 and held it in 19 quarters. The position peaked at $6.45M in Q3 2018. 135 funds tracked by Wall St. Rank hold ATRS as of Q3 2019.

  • JW Asset Management reported no remaining Antares Pharma, Inc. position as of Q3 2019 after selling out during the quarter.
  • JW Asset Management sold 380,524 Antares Pharma, Inc. shares in Q3 2019, an estimated $1.25M.
  • JW Asset Management first reported a position in Antares Pharma, Inc. in Q4 2014 and held it in 19 quarters.
  • JW Asset Management's Antares Pharma, Inc. position peaked at $6.45M in Q3 2018.
  • 135 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q3 2019.

Based on JW Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.